These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33535661)

  • 1.
    Alizadeh E; Behlol Ayaz Ahmed K; Raja Solomon V; Gaja V; Bernhard W; Makhlouf A; Gonzalez C; Barreto K; Casaco A; Geyer CR; Fonge H
    Cancers (Basel); 2021 Feb; 13(3):. PubMed ID: 33535661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical Evaluation of an Engineered Single-Chain Fragment Variable-Fragment Crystallizable Targeting Human CD44.
    Diebolder P; Mpoy C; Scott J; Huynh TT; Fields R; Spitzer D; Bandara N; Rogers BE
    J Nucl Med; 2021 Jan; 62(1):137-143. PubMed ID: 32513906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A radiopharmaceutical [
    Tang Y; Hu Y; Liu W; Chen L; Zhao Y; Ma H; Yang J; Yang Y; Liao J; Cai J; Chen Y; Liu N
    Nucl Med Biol; 2019 Mar; 70():23-31. PubMed ID: 30826708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous Imaging and Therapy Using Epitope-Specific Anti-Epidermal Growth Factor Receptor (EGFR) Antibody Conjugates.
    Tikum AF; Nambisan AK; Ketchemen JP; Babeker H; Khan MN; Torlakovic EE; Fonge H
    Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nimotuzumab Site-Specifically Labeled with
    Solomon VR; Barreto K; Bernhard W; Alizadeh E; Causey P; Perron R; Gendron D; Alam MK; Carr A; Geyer CR; Fonge H
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33233524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Near infrared imaging of epidermal growth factor receptor positive xenografts in mice with domain I/II specific antibody fragments.
    Bernhard W; El-Sayed A; Barreto K; Gonzalez C; Fonge H; Geyer CR
    Theranostics; 2019; 9(4):974-985. PubMed ID: 30867810
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Wyszatko K; Janzen N; Silva LR; Kwon L; Komal T; Ventura M; Venugopal C; Singh SK; Valliant JF; Sadeghi S
    EJNMMI Res; 2024 Mar; 14(1):29. PubMed ID: 38498285
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Chekol R; Solomon VR; Alizadeh E; Bernhard W; Fisher D; Hill W; Barreto K; DeCoteau JF; Parada AC; Geyer CR; Fonge H
    Oncotarget; 2018 Mar; 9(24):17117-17132. PubMed ID: 29682209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET imaging of epidermal growth factor receptor expression in tumours using 89Zr-labelled ZEGFR:2377 affibody molecules.
    Garousi J; Andersson KG; Mitran B; Pichl ML; Ståhl S; Orlova A; Löfblom J; Tolmachev V
    Int J Oncol; 2016 Apr; 48(4):1325-32. PubMed ID: 26847636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-specifically labeled
    Kristensen LK; Christensen C; Jensen MM; Agnew BJ; Schjöth-Frydendahl C; Kjaer A; Nielsen CH
    Theranostics; 2019; 9(15):4409-4420. PubMed ID: 31285769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Removal of Fc Glycans from [
    White JM; Keinänen OM; Cook BE; Zeglis BM; Gibson HM; Viola NT
    Mol Pharm; 2020 Jun; 17(6):2099-2108. PubMed ID: 32330387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron-Emission Tomography of HER2-Positive Breast Cancer Xenografts in Mice with
    Al-Saden N; Lam K; Chan C; Reilly RM
    Mol Pharm; 2018 Aug; 15(8):3383-3393. PubMed ID: 29957952
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Price EW; Carnazza KE; Carlin SD; Cho A; Edwards KJ; Sevak KK; Glaser JM; de Stanchina E; Janjigian YY; Lewis JS
    J Nucl Med; 2017 Sep; 58(9):1386-1394. PubMed ID: 28280216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical evaluation of the theranostic potential of
    Wu Y; Li T; Zhang X; Jing H; Li F; Huo L
    EJNMMI Radiopharm Chem; 2024 Jan; 9(1):5. PubMed ID: 38194043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immuno-PET Imaging of CD30-Positive Lymphoma Using 89Zr-Desferrioxamine-Labeled CD30-Specific AC-10 Antibody.
    Rylova SN; Del Pozzo L; Klingeberg C; Tönnesmann R; Illert AL; Meyer PT; Maecke HR; Holland JP
    J Nucl Med; 2016 Jan; 57(1):96-102. PubMed ID: 26514172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical Evaluation of [
    Oroujeni M; Garousi J; Andersson KG; Löfblom J; Mitran B; Orlova A; Tolmachev V
    Cells; 2018 Sep; 7(9):. PubMed ID: 30231504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ImmunoPET Imaging Identifies the Optimal Timepoint for Combination Therapy in Xenograft Models of Triple-Negative Breast Cancer.
    Li Z; Belitzky E; Blaha O; Cavaliere A; Katz SR; Aboian M; Melegari L; Rajabimoghadam K; Kurpiewski S; Zhu X; Marquez-Nostra B
    Cancers (Basel); 2023 Mar; 15(5):. PubMed ID: 36900378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron Emission Tomography Imaging of Platelet-Derived Growth Factor Receptor β in Colorectal Tumor Xenograft Using Zirconium-89 Labeled Dimeric Affibody Molecule.
    Cai H; Shi Q; Tang Y; Chen L; Chen Y; Tao Z; Yang H; Xie F; Wu X; Liu N; Yang Y; Wu H; Tian R; Lu X; Li L
    Mol Pharm; 2019 May; 16(5):1950-1957. PubMed ID: 30986347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR-Targeted ImmunoPET of UMUC3 Orthotopic Bladder Tumors.
    Hoang TT; Mandleywala K; Viray T; Tan KV; Lewis JS; Pereira PMR
    Mol Imaging Biol; 2022 Aug; 24(4):511-518. PubMed ID: 35147837
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Solomon VR; Gonzalez C; Alizadeh E; Bernhard W; Hartimath SV; Barreto K; Geyer CR; Fonge H
    Eur J Med Chem; 2018 Sep; 157():437-446. PubMed ID: 30103192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.